Glucagon Kit
Product Images NDC 85766-065

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 85766-065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure diagram showing the amino acid sequence of glucagon, a peptide hormone. The sequence is depicted in a circular arrangement labeled from 1 to 29, starting at the N-terminal histidine (His) and ending at the C-terminal threonine (Thr). Each amino acid residue is represented within a circle along the peptide chain.*

FDA Label Image

Figure 1 (Image 02)

A line graph depicting blood glucose concentrations (mg/dL) over time (hours). The graph shows an initial rise in glucose levels, peaking before gradually decreasing and stabilizing between 1.5 and 4 hours.*

FDA Label Image

Figure 2 (Image 03)

A pharmacokinetic line graph showing glucagon concentration (ng/mL) over time (hours). The curve rises steeply to a peak between 0.3 and 0.5 hours before declining gradually and leveling off near zero by 4 hours. Error bars indicate variability at each time point.*

FDA Label Image

Figure A (Image 04)

An exploded diagram of a glucagon kit showing labeled parts including a vial containing powder, rubber stopper, flip-off seal, needle protector, prefilled syringe with attached needle containing diluent, backstop and plastic clip, and plunger.*

FDA Label Image

Figure B (Image 05)

An instructional illustration showing a hand holding and twisting the cap of a vial or syringe, indicated by a directional arrow pointing upward, likely demonstrating step in preparing or opening the Glucagon kit for use.*

FDA Label Image

Figure C (Image 06)

An instructional illustration showing two hands preparing a syringe by drawing fluid from a vial, demonstrating the step of filling the syringe before injection.*

FDA Label Image

Figure D (Image 07)

An instructional illustration showing a hand grasping a small item, positioned over a curved arrow indicating a twisting or rotating motion. The image likely demonstrates how to manipulate a component of the Glucagon kit by Sportpharm LLC.*

FDA Label Image

Figure E (Image 08)

An instructional illustration showing a hand holding a syringe and vial, with an arrow indicating the direction to insert or push. The image is related to preparation or administration steps, likely for the Glucagon kit by Sportpharm LLC.*

FDA Label Image

Label (Image 09)

Glucagon Emergency Injection Kit packaging label relabeled for SportPharm, showing the product name, NDC 85766-065-01, quantity of 1, and manufacturing details for Mylan Pharmaceuticals Inc. The label includes lot and batch placeholders and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.